Altamira Therapeutics Ltd. (CYTOF)
OTCMKTS · Delayed Price · Currency is USD
0.0900
+0.010012 (12.52%)
At close: Oct 15, 2026
Altamira Therapeutics Market Cap
Altamira Therapeutics has a market cap or net worth of $514.39 thousand as of October 16, 2026. It is the 50,286th most valuable company in the world and the 6,936th biggest in the United States. Its market cap has increased by 12.50% in one year.
Market Cap
514.39K
Enterprise Value
1.30M
Revenue
n/a
Global Rank
Country Rank
#6,936 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since August 8, 2014, Altamira Therapeutics's market cap has decreased from 171.70M to 514.39K, a decrease of -99.70%. That is a compound annual growth rate of -37.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 514.39K | -2.69% |
| Dec 31, 2025 | 528.62K | 40.64% |
| Dec 31, 2024 | 375.87K | -72.84% |
| Dec 29, 2023 | 1.38M | -75.59% |
| Dec 30, 2022 | 5.67M | -78.93% |
| Dec 31, 2021 | 26.91M | -10.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Agentix | 801.34K |
| Helix BioMedix | 739.29K |
| SQZ Biotechnologies Company | 707.79K |
| Regenerative Medical Technology Group | 562.46K |
| Orgenesis | 555.63K |
| Neon Bloom | 488.20K |
| CERo Therapeutics Holdings | 455.53K |
| ZyVersa Therapeutics | 388.60K |